
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.050 | 3.050 | 0.000 |
Shares | 96.950 | 96.950 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.721 | 15.738 |
Price to Book | 1.562 | 2.639 |
Price to Sales | 1.044 | 1.857 |
Price to Cash Flow | 9.079 | 10.188 |
Dividend Yield | 3.369 | 3.415 |
5 Years Earnings Growth | 6.940 | 8.146 |
Name | Net % | Category Average |
---|---|---|
Industrials | 21.270 | 12.399 |
Healthcare | 20.820 | 12.519 |
Consumer Defensive | 19.160 | 11.919 |
Technology | 15.300 | 15.218 |
Consumer Cyclical | 13.490 | 8.728 |
Communication Services | 8.310 | 6.431 |
Basic Materials | 1.640 | 3.891 |
Number of long holdings: 40
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sanwa Holdings Corp | JP3344400001 | 7.20 | 4,620.0 | +0.63% | |
PAX Global Technology | BMG6955J1036 | 5.37 | 6.02 | -1.47% | |
Ahold Delhaize | NL0011794037 | 5.04 | 35.17 | +0.46% | |
Alphabet A | US02079K3059 | 4.93 | 182.97 | +0.53% | |
Skyworks | US83088M1027 | 4.59 | 72.87 | -0.14% | |
Unilever | GB00B10RZP78 | 4.22 | 51.50 | -0.46% | |
Roche Holding Participation | CH0012032048 | 4.11 | 256.20 | +0.47% | |
Exor NV | NL0012059018 | 3.95 | 88.60 | -0.28% | |
Biogen | US09062X1037 | 3.44 | 128.46 | +0.75% | |
GSK plc | GB00BN7SWP63 | 3.40 | 1,421.50 | +1.35% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wealth AKL SEB EM Equities Hermes P | 459.74M | -1.79 | 1.59 | 2.50 | ||
Wealth Linde Partners Global Value | 265.26M | 12.32 | 4.82 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review